Fiercebiotech

Published September 15, 2026 · Updated September 16, 2026

GSK doubles down on Chimagen with $750M multiple myeloma wager - Fierce Biotech

Read the full story at Fiercebiotech

As 'cultural weight' of a psychedelic approval looms, FDA hearing focuses on access and safety ... Fierce Biotech · Fierce Healthcare. Our Events.